WallStSmart

Coca-Cola European Partners PLC (CCEP)vsCoca-Cola Consolidated Inc. (COKE)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 178% more annual revenue ($21.35B vs $7.69B). CCEP leads profitability with a 9.3% profit margin vs 7.2%. CCEP appears more attractively valued with a PEG of 2.69. COKE earns a higher WallStSmart Score of 59/100 (C).

CCEP

Buy

51

out of 100

Grade: C-

Growth: 5.3Profit: 7.0Value: 3.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

COKE

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 7.0Value: 6.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.97
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCEPSignificantly Overvalued (-88.1%)

Margin of Safety

-88.1%

Fair Value

$51.90

Current Price

$113.22

$61.32 premium

UndervaluedFair: $51.90Overvalued
COKEUndervalued (+54.8%)

Margin of Safety

+54.8%

Fair Value

$352.43

Current Price

$210.30

$142.13 discount

UndervaluedFair: $352.43Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP1 strengths · Avg: 10.0/10
Return on EquityProfitability
42.7%10/10

Every $100 of equity generates 43 in profit

COKE2 strengths · Avg: 10.0/10
Return on EquityProfitability
135.2%10/10

Every $100 of equity generates 135 in profit

Debt/EquityHealth
-5.2410/10

Conservative balance sheet, low leverage

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.4%4/10

4.4% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.473/10

Elevated debt levels

PEG RatioValuation
2.692/10

Expensive relative to growth rate

COKE4 concerns · Avg: 3.3/10
P/E RatioValuation
27.9x4/10

Moderate valuation

Altman Z-ScoreHealth
1.974/10

Grey zone — moderate risk

Profit MarginProfitability
7.2%3/10

7.2% margin — thin

PEG RatioValuation
3.042/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity.

Bull Case : COKE

The strongest argument for COKE centers on Return on Equity, Debt/Equity. Revenue growth of 10.6% demonstrates continued momentum.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : COKE

The primary concerns for COKE are P/E Ratio, Altman Z-Score, Profit Margin.

Key Dynamics to Monitor

COKE carries more volatility with a beta of 0.54 — expect wider price swings.

COKE is growing revenue faster at 10.6% — sustainability is the question.

CCEP generates stronger free cash flow (604M), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

COKE scores higher overall (59/100 vs 51/100) and 10.6% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Coca-Cola Consolidated Inc.

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Consolidated, Inc. produces, markets and distributes non-alcoholic beverages primarily products of The Coca-Cola Company in the United States. The company is headquartered in Charlotte, North Carolina.

Want to dig deeper into these stocks?